Mycophenolate mofetil is a powerful inhibitor of lymphocyte proliferation and has been used to prevent acute rejection of allografts since the early 1990s. Mycophenolate mofetil is also widely used as a glucocorticoid reducing agent to treat patients with various rheumatic diseases, including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), inflammation Myopathy and some systemic vasculitis.
Mycophenolate mofetil was developed by Roche Pharmaceuticals Co., Ltd., and the trade name of Mycophenolate mofetil from Roche is CELLCEPT. CELLCEPT was first approved by the NMPA for listing in China in 2004, and then generic drugs from local Chinese companies have also been listed successively. By 2020, there are many manufacturers in China’s mycophenolate mofetil market, among which Shanghai Roche Pharmaceuticals Co., Ltd. has the highest sales market share.
According to CRI’s research market, the sales of mycophenolate mofetil in the Chinese market have increased year by year from 2016 to 2020. In 2020, due to the impact of the Covid-19 epidemic on the overall medical diagnosis and treatment services, the growth rate of sales has decreased. However, the sales still reached CNY 921 million, with a CAGR of 6.54% from 2016 to 2020.
CRI expects that with the effective alleviation of the Covid-19 epidemic, the sales of mycophenolate mofetil in the Chinese market will have a restorative growth from 2021 to 2025. At the same time, compared with similar drugs, mycophenolate mofetil is safer and more effective. Based on these advantages, the sales volume and sales of mycophenolate mofetil in the Chinese market will continue to grow from 2021 to 2025.
-The impact of COVID-19 on China’s Mycophenolate Mofetil market
– Sales value of China’s Mycophenolate Mofetil 2016-2020
– Competitive landscape of China’s Mycophenolate Mofetil market
– Prices of Mycophenolate Mofetil in China
– Prices of Mycophenolate Mofetil in China by regions and manufacturers
– Analysis on factors affecting the development of China’s Mycophenolate Mofetil market
– Prospect of China’s Mycophenolate Mofetil market from 2021 to 2025